drugset / Trial / NCT03533387
Study of MN-166 (Ibudilast) Extended Release Tablet Formulations Compared With Capsules in Healthy Volunteers
RandomizedCrossoverOpen-labelOther
Summary
To compare the bioavailability and pharmacokinetic profiles of two different formulations MN-166 50mg, extended release (ER) tablets with MN-166 10mg capsules in a single-dose regimen in healthy volunteers
Timeline
- Start
- 2018-04-11
- Primary completion
- 2018-07-06
- Completion
- 2018-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibudilast | Small molecule | 10 mg | Oral |
| Subject | Ibudilast | Small molecule | 25 mg | Oral |
| Subject | Ibudilast | Small molecule | 50 mg | Oral |
Indications
No indication recorded.